MILTON FINEGOLD to Receptors, Cytoplasmic and Nuclear
This is a "connection" page, showing publications MILTON FINEGOLD has written about Receptors, Cytoplasmic and Nuclear.
Connection Strength
0.685
-
Xenobiotic Nuclear Receptor Signaling Determines Molecular Pathogenesis of Progressive Familial Intrahepatic Cholestasis. Endocrinology. 2018 06 01; 159(6):2435-2446.
Score: 0.117
-
Circadian Homeostasis of Liver Metabolism Suppresses Hepatocarcinogenesis. Cancer Cell. 2016 Dec 12; 30(6):909-924.
Score: 0.106
-
Mutations in the nuclear bile acid receptor FXR cause progressive familial intrahepatic cholestasis. Nat Commun. 2016 Feb 18; 7:10713.
Score: 0.100
-
Elevated copper impairs hepatic nuclear receptor function in Wilson's disease. J Clin Invest. 2015 Sep; 125(9):3449-60.
Score: 0.096
-
Activating CAR and ?-catenin induces uncontrolled liver growth and tumorigenesis. Nat Commun. 2015 Feb 09; 6:5944.
Score: 0.093
-
Farnesoid X receptor inhibits gankyrin in mouse livers and prevents development of liver cancer. Hepatology. 2013 Mar; 57(3):1098-106.
Score: 0.081
-
Combined deletion of Fxr and Shp in mice induces Cyp17a1 and results in juvenile onset cholestasis. J Clin Invest. 2011 Jan; 121(1):86-95.
Score: 0.070
-
Bile acids activate YAP to promote liver carcinogenesis. Cell Rep. 2013 Nov 27; 5(4):1060-9.
Score: 0.021